Marine Bacteriophages and Their Applications

A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Biotechnology Related to Drug Discovery or Production".

Deadline for manuscript submissions: 15 June 2024 | Viewed by 266

Special Issue Editor


E-Mail Website
Guest Editor
School of Science, Technology and Engineering, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia
Interests: microbial ecology and diversity; microbial systematics; biodiscovery; microbial biotechnology applied; environmental and industrial microbiology; marine microbiology; biological control; actinomycetology; bacteriophages
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bacteria are continually evolving into antibiotic-resistant strains due to their extraordinary ability to adapt to changes in their environment and displaying extraordinary combat strategies to survive despite continuously improved antibiotic mechanisms of actions. Alternative therapies are thus gaining importance, and one effective such therapy is “bacteriophage therapy”. However, in order to use them as potent therapeutic agents, a diverse range of phages have to be isolated. This can only be achieved by improving our understanding of the phage–host interactions in natural environments. One of these natural environments is the marine one—in particular, the marine sediments that support bacterial life are proven to contain a significant number of phages. 

I, therefore, invite contributions from scientists who are researching the development of bacteriophage therapy using marine origin phages to combat antibiotic-resistant bacteria or for other types of biotechnological applications. The Special Issue is intended to capture the advances and fill the gaps within the current literature to be able to contribute toward an improved understanding of marine bacteriophages and, in turn, their use in medicine and industry.

Dr. Ipek Kurtboke
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine bacteriophages
  • bacteriophage therapy
  • bacteriophage biological control
  • bacteriophage lysins
  • pathogenic bacteria of marine origin
  • host–phage interactions in the marine environments
  • bacteriophages in marine aquaculture and fisheries operations
  • seafood-associated bacteria and their phages

Published Papers

This special issue is now open for submission.
Back to TopTop